African Traditional Herbal Research Clinic THE ... - Blackherbals.com
African Traditional Herbal Research Clinic THE ... - Blackherbals.com
African Traditional Herbal Research Clinic THE ... - Blackherbals.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Continued from page 19- Burkina Faso: Meningitis<br />
Epidemics in Vaccinated Areas<br />
been immunized.<br />
"[Health researchers] are currently collecting information<br />
so as to identify the factors explaining the recurrence of<br />
the epidemic in districts where populations have been<br />
vaccinated", Ousmane Badolo, head of the epidemiologic<br />
surveillance department at the ministry of health, told<br />
IRIN.<br />
Vaccination campaigns target people between 2 to 30<br />
years old; according to the ministry of health, 80 to 90<br />
percent of the victims of meningitis belong to that age<br />
group.<br />
A total of 714 people have died since 1 January out of<br />
7,184 cases.<br />
Several different bacteria can cause meningitis which is<br />
an inflammation of the protective membranes covering<br />
the central nervous system. The Neisseria sero-group is<br />
one of the most important to watch because it often leads<br />
to epidemics, experts say.<br />
Badolo, the epidemiologist, said that health research<br />
teams from the UN World Health Organization and USbased<br />
Centers for Disease Control and Prevention have<br />
<strong>com</strong>e to Burkina Faso to investigate. "This is the first<br />
time that such research is being conducted," Badolo said,<br />
adding that at this stage he could only guess why the<br />
vaccination programmes have not worked.<br />
"Perhaps it is because of population M displacement," he<br />
said, "for instance in gold mining areas people are often<br />
<strong>com</strong>ing and going."<br />
The health researchers will focus their work on the<br />
districts of Réo in the central west of the country, Boulsa<br />
in the central north, Titao in the north and in Sig-nonghin<br />
a district in the north of the capital Ouagadougou.<br />
The populations in each of those four districts were<br />
vaccinated last year yet each has reached epidemic<br />
thresholds.<br />
A total of five out of the country's 55 districts have<br />
reached the epidemic threshold and 14 others are on alert.<br />
Meanwhile, 3.5 million people have been vaccinated this<br />
year out of a population of 14 million. The government<br />
said it is in the process of procuring a million more<br />
vaccines with the help of UN Children's Agency<br />
UNICEF.<br />
[This report does not necessarily reflect the views of the<br />
United Nations ]<br />
http://allafrica.<strong>com</strong>/stories/200804110048.html<br />
☻☻☻☻☻☻<br />
Africa: New Meningitis<br />
Vaccine Nears Debut<br />
12 March 2009<br />
Dakar — A new vaccine that promises to eradicate<br />
meningitis in Africa will be rolled out in a mass<br />
campaign in West Africa this year, according to the UN<br />
World Health Organization (WHO).<br />
Twenty-five million doses of the meningococcal A, or<br />
MenA, vaccine are currently in production in India and<br />
the drug is expected to be introduced in Burkina Faso late<br />
2009.<br />
"This is the beginning of the end of the disease," said<br />
Mark LaForce, the director of the Meningitis Vaccine<br />
Project (MVP), an initiative of WHO and the non-profit<br />
PATH that has been developing the vaccine since 2003.<br />
The vaccine currently used in the region spanning from<br />
Senegal to Ethiopia - called the 'meningitis belt' for its<br />
vulnerability to deadly outbreaks - offers at most two<br />
years of protection, according to MVP.<br />
While the disease is more deadly in the meningitis belt<br />
than anywhere else in the world, there have been no<br />
prevention vaccines for the strain found in Africa- until<br />
now, according to clinical trials with MenA.<br />
Recent studies with patients age one to 29 in India, Mali,<br />
and The Gambia have shown that the new vaccine will<br />
provide long-term protection. Lead researcher LaForce<br />
has said the drug "will allow the elimination of the<br />
meningococcal [meningitis] epidemics that have afflicted<br />
the continent [Africa] for more than 100 years."<br />
Months away from the vaccine's US$29-million donorfinanced<br />
debut in three countries - Burkina Faso, Mali<br />
and Niger - LaForce told IRIN the deadly bacteria that<br />
attack the spinal cord and brain lining cannot be wiped<br />
out overnight.<br />
"Look at polio and how long it took to eradicate that. We<br />
are looking at 10 years at least [for eradication]," he said.<br />
More than 45 years after the polio vaccine was licensed,<br />
there were still more than 1,600 infections worldwide in<br />
2008, according to WHO - down from 350,000 cases 20<br />
years ago.<br />
LaForce told IRIN the MenA vaccination campaign's<br />
goal is to reach "herd immunity", in which if at least 70<br />
percent of the population is immunised, then the entire<br />
population is protected.<br />
When asked if people who might refuse vaccinations<br />
could thwart herd immunity, LaForce said the response<br />
Continued on page 21<br />
-20- <strong>Traditional</strong> <strong>African</strong> <strong>Clinic</strong> April 2009